These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 17359485)
1. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease. Maca T; Mlekusch W; Doweik L; Budinsky AC; Bischof M; Minar E; Schillinger M Eur J Clin Invest; 2007 Mar; 37(3):180-6. PubMed ID: 17359485 [TBL] [Abstract][Full Text] [Related]
2. The relationship between lipoprotein(a) and the complications of diabetes mellitus. Koschinsky ML; Marcovina SM Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus. Wakabayashi I; Masuda H Clin Chim Acta; 2006 Nov; 373(1-2):127-31. PubMed ID: 16820145 [TBL] [Abstract][Full Text] [Related]
4. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications. Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119 [TBL] [Abstract][Full Text] [Related]
5. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes. Tseng CH Diabet Med; 2004 Jul; 21(7):724-9. PubMed ID: 15209765 [TBL] [Abstract][Full Text] [Related]
6. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus. Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261 [TBL] [Abstract][Full Text] [Related]
7. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus. Hsieh MC; Tien KJ; Perng DS; Hsiao JY; Chang SJ; Liang HT; Chen HC; Tu ST Metabolism; 2009 Apr; 58(4):504-9. PubMed ID: 19303971 [TBL] [Abstract][Full Text] [Related]
8. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease. Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860 [TBL] [Abstract][Full Text] [Related]
9. High risk levels of lipoprotein(a) in Pakistani patients with type 2 diabetes mellitus. Habib SS; Aslam M Saudi Med J; 2003 Jun; 24(6):647-51. PubMed ID: 12847596 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) concentrations in patients with type 2 diabetes mellitus without cardiovascular disease: relationship to metabolic parameters and diabetic complications. Tarkun I; Cetinarslan B; Cantürk Z Nutr Metab Cardiovasc Dis; 2002 Jun; 12(3):127-31. PubMed ID: 12325469 [TBL] [Abstract][Full Text] [Related]
11. Association of serum lipoprotein (a) with hypertension in diabetic patients. Nasri H Saudi J Kidney Dis Transpl; 2008 May; 19(3):420-7. PubMed ID: 18445903 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50]. Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307 [TBL] [Abstract][Full Text] [Related]
13. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome. Linnemann B; Voigt W; Nobel W; Janka HU Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):127-34. PubMed ID: 16636979 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for progression of peripheral arterial disease in large and small vessels. Aboyans V; Criqui MH; Denenberg JO; Knoke JD; Ridker PM; Fronek A Circulation; 2006 Jun; 113(22):2623-9. PubMed ID: 16735675 [TBL] [Abstract][Full Text] [Related]
16. Type D personality and mortality in peripheral arterial disease: a pilot study. Aquarius AE; Smolderen KG; Hamming JF; De Vries J; Vriens PW; Denollet J Arch Surg; 2009 Aug; 144(8):728-33. PubMed ID: 19687376 [TBL] [Abstract][Full Text] [Related]
17. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients. Durlach V; Gillery P; Bertin E; Grulet H; Gross A; Leutenegger M Diabetes Metab; 1998 Apr; 24(2):124-30. PubMed ID: 9592636 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein (a) levels and clinical correlations in CAPD patients. Lye WC; Hughes K; Leong SO; Lee EJ Adv Perit Dial; 1995; 11():131-3. PubMed ID: 8534686 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres. González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D; Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592 [TBL] [Abstract][Full Text] [Related]